Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis

Kidney International

Volumn 74, Issue 1, 2008, Pages 70-80

  Nagae, T ^a   Mori, K ^a   Mukoyama, M ^a   Kasahara, M ^a   Yokoi, H ^a   Suganami, T ^a   Sawai, K ^a   Yoshioka, T ^a   Koshikawa, M ^a   Saito, Y ^a   Ogawa, Y ^a   Kuwabara, T ^a   Tanaka, I ^a   Sugawara, A ^a   Kuwahara, T ^b   Nakao, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Cyclic AMP; Extracellular matrix; Fibroblast; Gene expression; TGF

Indexed keywords

ADRENOMEDULLIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART MUSCLE FIBROSIS; HYPERTENSION; KIDNEY FIBROSIS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; URETER OBSTRUCTION; VASODILATATION;

EID: 45249110189     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.98     Document Type: Article

References (50)

1. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
2. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
3. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
4. Basile DP. The transforming growth factor β system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999; 8: 21-30.
5. Yokoi H, Mukoyama M, Sugawara A et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002; 282: F933-F942.
6. Yokoi H, Mukoyama M, Nagae T et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004; 15: 1430-1440.
7. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
8. Eto T, Kitamura K. Adrenomedullin and its role in renal diseases. Nephron 2001; 89: 121-134.
9. Mukoyama M, Sugawara A, Nagae T et al. Role of adrenomedullin and its receptor system in renal pathophysiology. Peptides 2001; 22: 1925-1931.
10. Michibata H, Mukoyama M, Tanaka I et al. Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. Kidney Int 1998; 53: 979-985.
11. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412-4417.
12. Hirata Y, Hayakawa H, Suzuki Y et al. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995; 25: 790-795.
13. McLatchie LM, Fraser NJ, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-339.
14. Nagae T, Mukoyama M, Sugawara A et al. Rat receptor-activity- modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun 2000; 270: 89-93.
15. Withers DJ, Coppock HA, Seufferlein T et al. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett 1996; 378: 83-87.
16. Iwasaki H, Eguchi S, Shichiri M et al. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 1998; 139: 3432-3441.
17. Plank C, Hartner A, Klanke B et al. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis. Kidney Int 2005; 68: 1086-1095.
18. Tsuruda T, Kato J, Kitamura K et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res 1999; 43: 958-967.
19. Dobrzynski E, Wang C, Chao J et al. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000; 36: 995-1001.
20. Zhang JJ, Yoshida H, Chao L et al. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis and renal damage in hypertensive Dahl salt-sensitive rats. Hum Gene Ther 2000; 11: 1817-1827.
21. Nishikimi T, Mori Y, Kobayashi N et al. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 2002; 39: 1077-1082.
22. Shimosawa T, Shibagaki Y, Ishibashi K et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-111.
23. Kawai J, Ando K, Tojo A et al. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 2004; 109: 1147-1153.
24. Niu P, Shindo T, Iwata H et al. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 2004; 109: 1789-1794.
25. Luodonpaa M, Leskinen H, Ilves M et al. Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats. Am J Physiol Regul Integr Comp Physiol 2004; 286: R1085-R1092.
26. Maruyama H, Higuchi N, Nishikawa Y et al. Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther 2002; 13: 455-468.
27. Masaki T, Foti R, Hill PA et al. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 2003; 63: 1256-1264.
28. Buhlmann N, Leuthauser K, Muff R et al. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 1999; 140: 2883-2890.
29. Fraser NJ, Wise A, Brown J et al. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Pharmacol 1999; 55: 1054-1059.
30. Kuwasako K, Shimekake Y, Masuda M et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem 2000; 275: 29602-29609.
31. Wiggins R, Goyal M, Merritt S et al. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 1993; 68: 557-565.
32. Strutz F. Novel aspects of renal fibrogenesis. Nephrol Dial Transplant 1995; 10: 1526-1532.
33. Gonzalez-Cuadrado S, Bustos C, Ruiz-Ortega M et al. Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol 1996; 106: 518-522.
34. Chini EN, Choi E, Grande JP et al. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 1995; 215: 868-873.
35. Kohno M, Yasunari K, Minami M et al. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. J Am Soc Nephrol 1999; 10: 2495-2502.
36. Parameswaran N, Nambi P, Brooks DP et al. Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin. Eur J Pharmacol 1999; 372: 85-95.
37. Haneda M, Araki S, Sugimoto T et al. Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides. Kidney Int 1996; 50: 384-391.
38. Parameswaran N, Hall CC, Bomberger JM et al. Regulation of adrenomedullin signaling in kidney interstitial fibroblasts. Cell Physiol Biochem 2003; 13: 391-400.
39. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: F861-F875.
40. Moriyama T, Kawada N, Nagatoya K et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001; 59: 2095-2103.
41. Miyashita K, Itoh H, Arai H et al. The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology 2006; 147: 1642-1653.
42. Miyake S, Makimura M, Kanegae Y et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-1324.
43. Kanegae Y, Lee G, Sato Y et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995; 23: 3816-3821.
44. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-199.
45. Kasahara M, Mukoyama M, Sugawara A et al. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J Am Soc Nephrol 2000; 11: 1691-1701.
46. Chang CP, Pearse II RV, O'Connell S et al. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993; 11: 1187-1195.
47. Aiyar N, Rand K, Elshourbagy NA et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996; 271: 11325-11329.
48. Sakata J, Shimokubo T, Kitamura K et al. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921-927.
49. Tomoda Y, Kikumoto K, Isumi Y et al. Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro. Cardiovasc Res 2001; 49: 721-730.
50. Alchi B, Nishi S, Kondo D et al. Osteopontin expression in acute renal allograft rejection. Kidney Int 2005; 67: 886-896.